Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation

Garvey J. F., Taylor C. T., McNicholas W. T.

Source: Eur Respir J 2009; 33: 1195-1205
Journal Issue: May
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Garvey J. F., Taylor C. T., McNicholas W. T.. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009; 33: 1195-1205

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Obstructive sleep apnoea and COPD
Source: Eur Respir Mon 2013; 59: 135-143
Year: 2013


Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome?
Source: Eur Respir J 2008; 31: 1381-1382
Year: 2008


Control of breathing
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=44
Year: 2005

Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013



Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008

The role of inflammatory biomarkers in obstructive sleep apnea syndrome
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018

Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019


Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea
Source: International Congress 2015 – Obstructive sleep apnoea in adults and children
Year: 2015



Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors
Source: Eur Respir J 2003; 21: 977-984
Year: 2003



The association of chronic obstructive pulmonary disease and sleep apnea syndrome (overlap syndrome)
Source: Eur Respir J 2002; 20: Suppl. 38, 495s
Year: 2002

Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia
Source: Eur Respir J 2012; 39: 1492-1500
Year: 2012



Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005

Association between lipid peroxidation and inflammation in obstructive sleep apnoea
Source: Eur Respir J 2006; 28: 378-385
Year: 2006



Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010